Cilostazol enhances mobilization and proliferation of endothelial progenitor cells and collateral formation by modifying vasculo-angiogenic biomarkers in peripheral arterial disease.
Department of Internal Medicine, National Cheng Kung University College of Medicine and Hospital, Tainan, Taiwan. Electronic address: chaotinghsing@yahoo.com.tw.
Ting-Hsing
TH
Chao
Department of Biological Science, National Sun Yat-Sen University, Kaohsiung, Taiwan.
Shih-Ya
SY
Tseng
Department of Internal Medicine, Tainan Municipal Hospital, Tainan, Taiwan.
I-Chih
IC
Chen
Department of Radiology, National Cheng Kung University College of Medicine and Hospital, Tainan, Taiwan.
Yi-Shan
YS
Tsai
Department of Emergency Medicine, National Cheng Kung University Hospital, Tainan, Taiwan.
Yao-Yi
YY
Huang
Department of Internal Medicine, National Cheng Kung University College of Medicine and Hospital, Tainan, Taiwan.
Ping-Yen
PY
Liu
Department of Internal Medicine, National Cheng Kung University College of Medicine and Hospital, Tainan, Taiwan.
Horng-Yih
HY
Ou
Department of Internal Medicine, National Cheng Kung University College of Medicine and Hospital, Tainan, Taiwan.
Yi-Heng
YH
Li
Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Hua-Lin
HL
Wu
Department of Biological Science, National Sun Yat-Sen University, Kaohsiung, Taiwan.
Chung-Lung
CL
Cho
Department of Internal Medicine, National Cheng Kung University College of Medicine and Hospital, Tainan, Taiwan.
Liang-Miin
LM
Tsai
Department of Internal Medicine, National Cheng Kung University College of Medicine and Hospital, Tainan, Taiwan.
Jyh-Hong
JH
Chen
D015415:Biomarkers / Q000097:blood; D002465:Cell Movement / Q000187:drug effects / Q000502:physiology; D049109:Cell Proliferation / Q000187:drug effects*; D000077407:Cilostazol; D003097:Collateral Circulation / Q000187:drug effects / Q000502:physiology; D004311:Double-Blind Method; D042783:Endothelial Cells / Q000187:drug effects* / Q000378:metabolism; D005500:Follow-Up Studies; D006801:Humans; D009389:Neovascularization, Pathologic / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D058729:Peripheral Arterial Disease / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D011446:Prospective Studies; D013234:Stem Cells / Q000187:drug effects* / Q000378:metabolism; D013777:Tetrazoles / Q000494:pharmacology / Q000627:therapeutic use*
D015415:Biomarkers; D010975:Platelet Aggregation Inhibitors; D013777:Tetrazoles; D000077407:Cilostazol
Angiogenesis; Biological markers; Cilostazol; Peripheral arterial disease; Progenitor cells